1. Home
  2. Stock quotes
  3. Prelude Therapeutics Incorporated
  4. Financial Ratios
  5. EV/EBITDA Ratio
Prelude Therapeutics Incorporated logo
Prelude Therapeutics Incorporated PRLD
$ 1.3 46.4%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Prelude Therapeutics Incorporated EV/EBITDA Ratio 2011-2024 | PRLD

Annual EV/EBITDA Ratio Prelude Therapeutics Incorporated

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.15 0.186 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.186 -3.15 -1.48